You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / ABIM MOC / CE

Hyperkalemia in the Emergency Room: Improving Long-Term Outcomes With Effective Discharge

  • Authors: Matthew R. Weir, MD; W. Frank Peacock, MD; Craig I. Coleman, PharmD
  • CME / ABIM MOC / CE Released: 9/16/2022
  • Valid for credit through: 9/16/2023
Start Activity

  • Credits Available

    Physicians - maximum of 0.50 AMA PRA Category 1 Credit(s)™

    ABIM Diplomates - maximum of 0.50 ABIM MOC points

    Nurses - 0.50 ANCC Contact Hour(s) (0.5 contact hours are in the area of pharmacology)

    Pharmacists - 0.50 Knowledge-based ACPE (0.050 CEUs)

    IPCE - 0.50 Interprofessional Continuing Education (IPCE) credit

    You Are Eligible For

    • Letter of Completion
    • ABIM MOC points

Target Audience and Goal Statement

This activity is intended for nephrologists, cardiologists, primary care providers, nurses, and pharmacists.

The goal of this activity is that learners will be better able to manage chronic kidney disease (CKD)-related hyperkalemia, learn about new evidence and guidance for initiating appropriate treatment, educate their patients, and plan long-term, team-based patient follow-up after discharge. 

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Gaps in patient discharge on long-term potassium management after an acute hyperkalemic episode
    • Safety and efficacy of newer potassium binders in the management of hyperkalemia
    • Strategies for effective team-based patient discharge to improve patient outcomes in the management of CKD-related hyperkalemia


Disclosures

Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.


Moderator

  • Matthew R. Weir, MD

    Professor of Medicine
    Chief, Nephology Division
    Department of Medicine
    University of Maryland School of Medicine
    Baltimore, Maryland

    Disclosures

    Matthew R. Weir, MD, has the following relevant financial relationships:
    Consultant or advisor for: Akebia; AstraZeneca; Bayer; Boehringer Ingelheim; FibroGen; Janssen; Merck; Novo Nordisk; Vifor

Faculty

  • W. Frank Peacock, MD

    Professor of Emergency Medicine
    Baylor College of Medicine
    Houston, Texas

    Disclosures

    W. Frank Peacock, MD, has the following relevant financial relationships:
    Consultant or advisor for: Abbott; Brainbox Inc; Instrument Labs; Janssen; Osler; Roche; Siemens; Vifor
    Research funding from: Brainbox Inc; Instrument Labs; Salix
    Stock options from: Brainbox Inc; Braincheck Inc; Coagulo Inc; Fast Inc; Forrest Devices; Lucia Inc; Prevencio Inc; ScPharma; Trivirum Inc; Upstream Inc

  • Craig I. Coleman, PharmD

    Professor of Pharmacy
    University of Connecticut School of Pharmacy
    Storrs, Connecticut

    Disclosures

    Craig I. Coleman, PharmD, has the following relevant financial relationships:
    Consultant or advisor for: Alexion; AstraZeneca Rare Diseases; Bayer AG; Global Blood Therapeutics; Janssen Pharmaceuticals
    Speaker or member of speakers bureau for: Bayer AG; Janssen Pharmaceuticals
    Research funding from: Alexion; AstraZeneca Rare Diseases; Bayer AG; Janssen Pharmaceuticals
    Contracted researcher for: Alexion; AstraZeneca Rare Diseases; Bayer AG; Janssen Pharmaceuticals

Editors

  • George Boutsalis, PhD

    Senior Medical Education Director, Medscape, LLC

    Disclosures

    George Boutsalis, PhD, has no relevant financial relationships.

  • Cheryl Leigh Perkins, MD, RPh

    Medical Education Director, Medscape, LLC

    Disclosures

    Cheryl Leigh Perkins, MD, RPh, has no relevant financial relationships.

Compliance Reviewer/Nurse Planner

  • Stephanie Corder, ND, RN, CHCP

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Stephanie Corder, ND, RN, CHCP, has no relevant financial relationships.


Accreditation Statements



In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

This activity was planned by and for the healthcare team, and learners will receive 0.50 Interprofessional Continuing Education (IPCE) credit for learning and change.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

    Contact This Provider

    For Nurses

  • Awarded 0.50 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.50 contact hours are in the area of pharmacology.

    Contact This Provider

    For Pharmacists

  • Medscape designates this continuing education activity for 0.50 contact hour(s) (0.050 CEUs) (Universal Activity Number: JA0007105-0000-22-221-H01-P).

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / ABIM MOC / CE

Hyperkalemia in the Emergency Room: Improving Long-Term Outcomes With Effective Discharge

Authors: Matthew R. Weir, MD; W. Frank Peacock, MD; Craig I. Coleman, PharmDFaculty and Disclosures

CME / ABIM MOC / CE Released: 9/16/2022

Valid for credit through: 9/16/2023

processing....

Educational Impact Challenge

The goal of this activity is that learners will be better able to manage chronic kidney disease (CKD)-related hyperkalemia, learn about new evidence and guidance for initiating appropriate treatment, educate their patients, and plan long-term, team-based patient follow-up after discharge. 

Before you begin this activity, please assess your clinical knowledge by completing this brief survey. Answering these questions again after the activity will allow you to see what you learned and to compare your answers with those of your peers.

  • Print